Another Chinese executive at AstraZeneca suddenly resigns

K-LinePoet · 2026-04-08T13:43:51+00:00

On March 18, AstraZeneca China confirmed to First Financial Journalist that Huang Bin, a veteran who has been deeply involved with AstraZeneca for over 20 years, Vice President of AstraZeneca China, and head of Market Access, will be leaving his position. As of the time of this report, Huang Bin has not responded regarding his future plans. (First Financial)

K-LinePoet

2026-04-08 13:43:51

On March 18, AstraZeneca’s China team confirmed to a reporter from First Finance that Huang Bin, a veteran figure at AstraZeneca who has worked there for more than 20 years, and AstraZeneca China’s vice president and head of the market access department, will step down. As of the time of publication, Huang Bin has not responded about his future plans. (First Finance)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.